China Health Group Inc. (8225.HK)

HKD 0.19

(3.85%)

Market Cap (In HKD)

188.12 Million

Revenue (In HKD)

21.42 Million

Net Income (In HKD)

-58.01 Million

Avg. Volume

59.67 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.04-0.244
PE
-
EPS
-
Beta Value
-2.35
ISIN
KYG2117N1088
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Xia Guo MBA, MSc, Ph.D.
Employee Count
-
Website
https://www.chgi.net
Ipo Date
2003-07-10
Details
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.